Cleared Traditional

K992626 - SURE-WAY REUSABLE SHARPS CONTAINER

K992626 is an FDA 510(k) clearance for SURE-WAY REUSABLE SHARPS CONTAINER, manufactured by Sure-Way Systems, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K992626 · Sure-Way Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1999
Decision
133d
Days
Class 2
Risk

K992626 is an FDA 510(k) clearance for the SURE-WAY REUSABLE SHARPS CONTAINER. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Sure-Way Systems, Inc. (Wilmington, US). The FDA issued a Cleared decision on December 16, 1999 after a review of 133 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sure-Way Systems, Inc. devices

FDA 510(k) Submission Details - K992626

510(k) Number K992626 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 1999
Decision Date December 16, 1999
Days to Decision 133 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 129d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 442
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K992626.
NIPRO BLOOD COLLECTION NEEDLE
K992699 · Nipro Medical Corp. · Feb 2000
NIPRO LUER ADAPTOR
K992729 · Nipro Medical Corp. · Jan 2000
DISENTRONIC PENFINE INJECTION PEN NEEDLE
K994197 · Disetronic Medical Systems · Dec 1999
PUNCTUR-GUARD REVOLUTION HOLDER, MODEL 4750
K992091 · Bio-Plexus, Inc. · Sep 1999
MODIFICATION OF JMS NEEDLES AND JMS SYRINGES
K991904 · Jms Co., Ltd. · Aug 1999
K-PACK II (HYPODERMIC NEEDLE) 23G X 1, MODEL KN-2325RB, K-PACK II NEEDLE (HYPODERMIC NEEDLE) 25G X 1, MODEL KN-2525RB, K
K984576 · Terumo Europe N.V. · Jun 1999